18 results
Thumbnail

D2.413 - Diagnostic Value of the Basophil Degranulation Test in High-Risk Drug-Induced Anaphylaxis

Thumbnail

D2.415 - DRESS Syndrome induced by Lenalidomide

Thumbnail

D2.408 - Hypersensitivity Reactions to Corticosteroids: A Retrospective Cohort Study

Thumbnail

D2.414 - Diagnostic Distribution of Patch, Delayed-Reading Intradermal, and Drug Provocation Tests in Delayed-Type Cutaneous Drug Hypersensitivity

Thumbnail

D2.416 - Skin reaction to Kaftrio/Kalydeco (CFTR) in cystic fibrosis: safe reintroduction using an outpatient desensitization protocol

Thumbnail

D2.419 - DRESS syndrome in the context of carbamazepine treatment - case report

Thumbnail

D2.420 - A challenging case of cardiotoxicity following palbociclib therapy

Thumbnail

D2.350 - Exploring the Psychological Burden of Hereditary Angioedema Using the Pictorial Representation of Illness and Self Measure (PRISM): Updated Insights from a Prospective Real-Life Cohort

Thumbnail

D2.351 - Germline Variant in the GNAI2 Gene Associated with Severe Immune Dysregulation and Autoimmune Hemolytic Anemia in a Pediatric Patient

Thumbnail

D2.352 - Epidermodysplasia verruciformis as a sign for STK4 deficiency

Thumbnail

D2.353 - Same Disease, Different Clinical Phenotypes: A20 Haploinsufficiency

Thumbnail

D2.354 - Evaluation of Subjective Sleep Quality and Psychological Status in Adult Patients with Inborn Errors of Immunity

Thumbnail

D2.362 - Clinical and Immunological Characteristics of Non-Infectious Complications in Common Variable Immunodeficiency: A Single-Center Retrospective Evaluation in Adult Patients with CVID

Thumbnail

D2.363 - Immunologic Basis of Coexisting Slowly Progressive Insulin-Dependent Diabetes Mellitus (SPIDDM) and Generalized Myasthenia Gravis (MG)

Thumbnail

D2.349 - RAPIDe‑3 Patient Voices: Qualitative Insights from the Phase 3 Study of Oral Deucrictibant for On-Demand Treatment of Hereditary Angioedema Attacks

Thumbnail

D2.357 - Reductions in Hereditary Angioedema Attacks among Patients with C1 Esterase Inhibitor Deficiency who Switched from Another Long-Term Prophylaxis to Berotralstat

Thumbnail

D2.360 - Hereditary Angioedema Attack Rates among Patients with Normal C1 Esterase Inhibitor Before and After Switching from Another Long-Term Prophylaxis to Berotralstat

Thumbnail

D2.361 - Reductions in Healthcare Resource Utilization in Adolescents with Hereditary Angioedema on Berotralstat